Subscribe To

Price Alert Latest News Economic Calendar News

MCD / Apollon Formularies names Dr Archibald McDonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served in various capacities throughout his 35-year tenure at the University of the West Indies, including as vice principal, head of the department of surgery, radiology, anesthesia and intensive care and as chief executive officer, the medical cannabis pharmaceutical company said in a statement. Read More

Demo Live Account See Partner Details

Content Topics

Apollon

Formularies

Names

Archibald

Mcdonald

Clinical

Trials

Director

Stock

MCD

Posted: Jan 21 2022, 07:57

Author Name: Proactive Investors

MCD News

By The Motley Fool
November 4, 2023

1 Huge Green Flag for McDonald's Stock in 2023

The fast food giant's profit margin is hovering near record territory. But keep a close watch on customer traffic going forward.

By InvestorPlace
November 2, 2023

Invest in the Future: Buy & Hold Visa, McDonald's and Microsoft Forever

The uncertainty surrounding interest rates and the mixed earnings have pressured investor sentiment. With the holiday season upon us, now is also a go

By Zacks Investment Research
November 1, 2023

McDonald's (MCD) Beats Overall in Q3: ETFs to Benefit

McDonald's Corporation (MCD) reported third-quarter 2023 results, with earnings and revenues beating the Zacks Consensus Estimate.

By New York Post
October 31, 2023

McDonald's McCrispy chicken sandwich becomes $1B brand worldwide after getting fresh name

McDonald's revealed in an earnings call Monday that its rebranded Crispy Chicken Sandwiches — which are now known as the McCrispy — have grown to

By Fox Business
October 31, 2023

McDonald's CEO warns California minimum wage hike will hurt franchisees

McDonald's is warning that California's minimum wage hike to $20 an hour for minimum wage workers will have an impact on franchisees as they deal with

By 24/7 Wall Street
October 31, 2023

McDonald's Food Prices Rise — in California

Most retailers must be unhappy with a new law that brings the minimum wage up to $20.

By Invezz
October 30, 2023

Should you buy McDonald's stock after its Q3 earnings?

McDonald's Corp (NYSE: MCD) ended close to 2.0% up on Monday after reporting solid results for its third financial quarter. McDonald's stock has upsid

By Market Watch
October 30, 2023

McDonald's set up well for 2024 with catalysts ahead, says Wells Fargo

McDonald's Corp., which reported better-than-expected third-quarter results before market open Monday, is well positioned for 2024, according to Wells

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.